Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company was founded on April 9, 2024 and is headquartered in London, United Kingdom.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
315
Frequently Asked Questions
What is Market Cap of Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A market cap is $2.65B.
What is the 52-week high for Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A 52 week high is $37.34 as of September 17, 2025.
What is the 52-week low for Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A 52 week low is $17.82 as of September 17, 2025.
What is Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A stock price today?
Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A stock price today is $35.51.
What was Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A stock price yesterday?
Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A stock price yesterday was $35.77.
What is the PE ratio of Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A’s P/E ratio is 870.32.
What is the Price-to-Book ratio of Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A P/B ratio is 5.3497.
What is the 50-day moving average of Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A 50-day moving average is $32.08.
How many employess does Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A has?
Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A has 315 employees.
